Toggle navigation
Home
Search
Services
Blog
Contact
About
Biologically Relevant Alpha Helix Stabilization
Erlanson, Daniel A.
Sunesis Pharmaceuticals, Inc., South San Francisco, CA, United States
Search 5 grants from Daniel Erlanson
Search grants from Sunesis Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Trial to Explore the Benefits of Antimicrobial Self-Sanitizing Surfaces on Bio-Burden Levels and Healthcare-Acquired Infections.
MAP Kinase Regulation of Substrate Proteins
TPR Proteins in Steroid Receptor Signaling &Physiology
Ergonomic Assessment of Vineyard Systems
Social Support on Recovery From Heart Surgery
Recently added grants:
Cholinergic contribution to pupil-linked arousal
The effects of BTNL2 on experimental autoimmune encephalomyelitis
Transitions in Care for Older Nursing Home Residents with Dementia from Entry to Death: a retrospective cohort study, 2014-2019
Patient-Specific Strategies for Capsular Repair Following Shoulder Dislocations
Transcriptomic and epigenomic landscape of neurodegenerative disease models
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
7F32GM019454-02
Application #
2906476
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Lohrey, Nancy
Project Start
1998-12-21
Project End
Budget Start
1998-12-21
Budget End
1999-03-08
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Sunesis Pharmaceuticals, Inc.
Department
Type
DUNS #
City
South San Francisco
State
CA
Country
United States
Zip Code
94080
Comments
Be the first to comment on Daniel Erlanson's grant